A/Professor Nathan Lawrentschuk
A/Professor Nathan Lawrentschuk
Verified email at unimelb.edu.au - Homepage
Title
Cited by
Cited by
Year
Sensitivity, specificity, and predictors of positive 68Ga–prostate-specific membrane antigen positron emission tomography in advanced prostate cancer: a systematic review and …
M Perera, N Papa, D Christidis, D Wetherell, MS Hofman, DG Murphy, ...
European urology 70 (6), 926-937, 2016
7592016
The role of focal therapy in the management of localised prostate cancer: a systematic review
M Valerio, HU Ahmed, M Emberton, N Lawrentschuk, M Lazzeri, ...
European urology 66 (4), 732-751, 2014
3322014
Gallium-68 prostate-specific membrane antigen positron emission tomography in advanced prostate cancer—updated diagnostic utility, sensitivity, specificity, and distribution …
M Perera, N Papa, M Roberts, M Williams, C Udovicich, I Vela, ...
European urology 77 (4), 403-417, 2020
3002020
Prostate-specific membrane antigen PET-CT in patients with high-risk prostate cancer before curative-intent surgery or radiotherapy (proPSMA): a prospective, randomised …
MS Hofman, N Lawrentschuk, RJ Francis, C Tang, I Vela, P Thomas, ...
The Lancet 395 (10231), 1208-1216, 2020
2692020
Dynamic contrast-enhanced–magnetic resonance imaging evaluation of intraprostatic prostate cancer: correlation with radical prostatectomy specimens
P Puech, E Potiron, L Lemaitre, X Leroy, GP Haber, S Crouzet, K Kamoi, ...
Urology 74 (5), 1094-1099, 2009
2352009
Prevention and management of complications following radical cystectomy for bladder cancer
N Lawrentschuk, R Colombo, OW Hakenberg, SP Lerner, W Månsson, ...
European urology 57 (6), 983-1001, 2010
2282010
Correlation of hypoxic cell fraction and angiogenesis with glucose metabolic rate in gliomas using 18F-fluoromisonidazole, 18F-FDG PET, and immunohistochemical studies
LM Cher, C Murone, N Lawrentschuk, S Ramdave, A Papenfuss, ...
Journal of Nuclear Medicine 47 (3), 410-418, 2006
2172006
‘Prostatic evasive anterior tumours’: the role of magnetic resonance imaging
N Lawrentschuk, MA Haider, N Daljeet, A Evans, A Toi, A Finelli, ...
BJU international 105 (9), 1231-1236, 2010
1972010
Impact of multiparametric endorectal coil prostate magnetic resonance imaging on disease reclassification among active surveillance candidates: a prospective cohort study
D Margel, SA Yap, N Lawrentschuk, L Klotz, M Haider, K Hersey, A Finelli, ...
The Journal of urology 187 (4), 1247-1252, 2012
1822012
Sepsis and ‘superbugs’: should we favour the transperineal over the transrectal approach for prostate biopsy?
JP Grummet, M Weerakoon, S Huang, N Lawrentschuk, M Frydenberg, ...
BJU international 114 (3), 384-388, 2014
1782014
The social media revolution is changing the conference experience: analytics and trends from eight international meetings
SE Wilkinson, MY Basto, G Perovic, N Lawrentschuk, DG Murphy
BJU international 115 (5), 839-846, 2015
1752015
The role of magnetic resonance imaging in the diagnosis and management of prostate cancer
J Thompson, N Lawrentschuk, M Frydenberg, L Thompson, P Stricker, ...
BJU international 112, 6-20, 2013
1542013
Focal laser ablation for prostate cancer followed by radical prostatectomy: validation of focal therapy and imaging accuracy
U Lindner, N Lawrentschuk, RA Weersink, SRH Davidson, O Raz, ...
European urology 57 (6), 1111-1114, 2010
1532010
Functional imaging of intratumoral hypoxia
SS Foo, DF Abbott, N Lawrentschuk, AM Scott
Molecular Imaging & Biology 6 (5), 291-305, 2004
1532004
Radical prostatectomy findings in patients in whom active surveillance of prostate cancer fails
AS Duffield, TK Lee, H Miyamoto, HB Carter, JI Epstein
The Journal of urology 182 (5), 2274-2279, 2009
1522009
Stereotactic abative body radiotherapy (SABR) for oligometastatic prostate cancer: a prospective clinical trial
S Siva, M Bressel, DG Murphy, M Shaw, S Chander, J Violet, KH Tai, ...
European urology 74 (4), 455-462, 2018
1392018
The role of magnetic resonance imaging in targeting prostate cancer in patients with previous negative biopsies and elevated prostate-specific antigen levels
N Lawrentschuk, N Fleshner
BJU international 103 (6), 730, 2009
1242009
Assessing regional hypoxia in human renal tumours using 18F‐fluoromisonidazole positron emission tomography
N Lawrentschuk, AMT Poon, SS Foo, LGJ Putra, C Murone, ID Davis, ...
BJU international 96 (4), 540-546, 2005
1192005
Multidetector computed tomography vs magnetic resonance imaging for defining the upper limit of tumour thrombus in renal cell carcinoma: a study and review
N Lawrentschuk, J Gani, R Riordan, S Esler, DM Bolton
BJU international 96 (3), 291-295, 2005
1172005
Mobile phone interference with medical equipment and its clinical relevance: a systematic review
N Lawrentschuk, DM Bolton
Medical journal of Australia 181 (3), 145-149, 2004
1152004
The system can't perform the operation now. Try again later.
Articles 1–20